This announcement is a separate document:
康泰生物：深圳康泰生物制品股份有限公司向不特定对象发行可转换公司债券第二次临时受托管理事务报告（2022年度）
Kangtai Biotech: Second Interim Management Report on the Issuance of Convertible Corporate Bonds by Shenzhen Kangtai Biological Products Co., Ltd. to unspecified targets (2022)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated